Horizon Pharma adds directors
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Horizon Pharma PLC added Pascale Witz and James Shannon to the company's board.
Witz was most recently the executive vice president of global diabetes and cardiovascular at Sanofi, while Shannon is the former chief medical officer of GlaxoSmithKline plc.
